Use of Sertoli cell transplants to provide local immunoprotection for tissue grafts

Bibliography

• SHAPIRO AM, LAKEY JR, RYAN EA et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl. I Med. (2000) 343(4):230–238.
   PubMed Web of Science ®Google Scholar
• •Demonstration of 100% successful human allogeneic islet transplantation for the treatment of type I diabetes.
   Google Scholar
• COLTON CK: Implantable biohybrid artificial organs. Cell Transplant. (1995) 4(4):415–436.
   PubMed Web of Science ®Google Scholar
• •Excellent review of cell encapsulation.
   Google Scholar
• BYRNE GW, MCCURRY KR, MARTIN MJ et al: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation (1997) 63(1):149–155.
   PubMed Web of Science ®Google Scholar
• COSTA C, ZHAO L, BURTON WV et al.: Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J. (1999) 13(13):1762–1773.
   PubMed Web of Science ®Google Scholar
• VAN DEN BOGAERDE J, WHITE DJ: Xenogeneic transplantation. Br. Med. Bull. (1997) 53(4):904–920.
   PubMed Web of Science ®Google Scholar
• AO Z, KORBUTT GS, WARNOCK GL et al.: Microencapsulation improves canine islet survival in viva Transplant. Proc. (1995) 27(6):3349.
   Google Scholar
• GARFINKEL MR, HARLAND RC, OPARA EC: Optimization of the microencapsulated islet for transplantation. Surg. Res. (1998) 76(1):7–10.
   PubMed Web of Science ®Google Scholar
• LACY PE: Pancreatic islet cell transplant. Mt. Sinai J. Med. (1994) 61(1):23–31.
   PubMed Web of Science ®Google Scholar
• LANZA RP, BEYER AM, STARUK JE, CHICK WL: Biohybrid artificial pancreas. Long-term function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation (1993) 56(5):1067–1072.
   Google Scholar
• LIM F: Microencapsulation of living mammalian cells. Adv. Bietechnel Processes (1988) 7:185–197.
   PubMedGoogle Scholar
• HILL RS, CRUISE GM, HAGER SR et aL: Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann. NY Acad. Sci. (1997) 831:332–343.
   Google Scholar
• RAMSOONDAR JJ, MACHATY Z, COSTA C et al.: Production of alpha 1,3-galactosyltransferase-knockout cloned pigs expressing human alpha 1,2-fucosylosyltransferase. Biel Repred. (2003) 69(2):437–445.
   PubMed Web of Science ®Google Scholar
• LAVITRANO M, BACCI ML, FORNI M et al.: Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation. Proc. Natl. Acad. Sci. USA (2002) 99(22):14230–14235.
   PubMed Web of Science ®Google Scholar
• BARKER CE BILLINGHAM RE: Immunologically privileged sites. In: Advances M Immunology Kunkel MG, Dixon FJ (Eds), Academic Press, New York, USA (1977).
   Google Scholar
• •Excellent historical reference on the transplantation of tissues into privileged sites.
   Google Scholar
• SELAWRY H: Islet transplantation to immunoprivileged sites. In: bninunentedulatien of Pancreatic Islets Lanza RP, Chick W (Eds), R.G. Landes Company, Austin, TX, USA (1994):75–86.
   Google Scholar
• SELAWRY HP, WHITTINGTON K: Extended allograft survival of islets grafted into intra-abdominally placed testis. Diabetes (1984) 33(4):405–406.
   PubMed Web of Science ®Google Scholar
• ••Original demonstration of islet allografts surviving in the testes and reversing diabetes.
   Google Scholar
• RUSSELL LD, GRISWOLD MD: The Sertoli Cell. Russell LD, Griswold MD (Eds), Cache River Press, Clearwater, FL (1993):1–801.
   Google Scholar
• •Comprehensive reference on Sertoli cell biology.
   Google Scholar
• MARGOLIS RN, HOLUP JJ, SELAWRY HP: Effects of intratesticular islet transplantation on hepatic glycogen metabolism in the rat. Diabetes Res. Pract. (1986) 2(5):291–299.
   PubMedGoogle Scholar
• WHITTINGTON KB, SOLOMON SS, LU ZN, SELAWRY HP: Islet allografts in the cryptorchid testes of spontaneously diabetic BB/NA/or dp rats: response to glucose, glipizide, and arginine. Endocrinology (1991) 128(6):2671–2677.
   PubMed Web of Science ®Google Scholar
• SELAWRY HP, WHITTINGTON KB, BELLGRAU D: Abdominal intratesticular islet-xenograft survival in rats. Diabetes (1989) 38\(Suppl. 1):220–223.
   Google Scholar
• SELAWRY H, GABER AO: Intratesticular islet allograft survival in the Rhesus monkey without sustained immunosuppression. Cell Transplant. (2004) (In Press).
   Google Scholar
• GORES PF, HAYES DH, COPELAND MJ et al: Long-term survival of intratesticular porcine islets in nonimmunosuppressed beagles. Transplantation (2003) 75(5):613–618.
   PubMed Web of Science ®Google Scholar
• ••Convincing demonstration of xenogeneic islet survival in a large animal model.
   Google Scholar
• SELAWRY HP, WHITTINGTON KB: Prolonged intratesticular islet allograft survival is not dependent on local steroidogenesis. Horm. Metab. Res. (1988) 20(9):562–565.
   PubMed Web of Science ®Google Scholar
• CAMERON DF, WHITTINGTON K, SCHULTZ RE, SELAWRY HP: Successful islet/abdominal testis transplantation does not require Leydig cells. Transplantation (1990) 50(4):649–653.
   PubMed Web of Science ®Google Scholar
• SELAWRY HP, CAMERON DF: Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. (1993) 2(2):123–129.
   PubMed Web of Science ®Google Scholar
• KORBUTT GS, ELLIOTT JF, RAJOTTE RV: Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes (1997) 46(2):317–322.
   PubMed Web of Science ®Google Scholar
• •First demonstration by another investigator confirming Dr Selawry's allogeneic Sertoli cell and islet transplant results.
   Google Scholar
• KORBUTT GS, SUAREZ-PINZON WL, POWER RF, RAJOTTE RV, RABINOVITCH A: Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia (2000) 43(4):474–480.
   PubMed Web of Science ®Google Scholar
• SUAREZ-PINZON W, KORBUTT GS, POWER R et al.: Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta 1-dependent mechanism. Diabetes (2000) 49(11):1810–1818.
   PubMed Web of Science ®Google Scholar
• WRIGHT JR JR, POHAJDAK B: Cell therapy for diabetes using piscine islet tissue. Cell Transplant. (2001) 10(2):125–143.
   PubMed Web of Science ®Google Scholar
• YANG H, WRIGHT JR JR: Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation (1999) 67(6):815–820.
   PubMed Web of Science ®Google Scholar
• YANG H, AL-JAZAERI A, WRIGHT JR JR: The immunoprotective effect of Sertoli cells coencapsulated with islet xenografts is not dependent upon Fas ligand expression. Cell Transplant. (2002) 11(8):799–801.
   PubMed Web of Science ®Google Scholar
• KIN T, RAJOTTE RV, DUFOUR JM, KORBUTT GS: Development of an immunoprivileged site to prolong islet allograft survival. Cell Transplant. (2002) 11(6):547–552.
   PubMed Web of Science ®Google Scholar
• CALAFIORE R, LUCA G, CALVITTI M et al.: Cellular support systems for alginate microcapsules containing islets, as composite bioartificial pancreas. Ann. NY Acad. Sci. (2001) 944:240–251.
   PubMed Web of Science ®Google Scholar
• LUCA G, CALVITTI M, NERI LM et al: Mitogenic effects of rat Sertoli cells on adult homologous islet beta-cells: M vitro and M vivo studies. Transplant. Proc. (2001) 33(1-2):681–682.
   PubMed Web of Science ®Google Scholar
• TAKEDA Y, GOTOH M, DONO K et al: Acceptance of islet allografts transplanted with Fas ligand expressing testicular allografts. Transplant. Proc. (1999) 31(1-2):624.
   PubMed Web of Science ®Google Scholar
• ••
   Google Scholar
• FREEMAN TB, WIDNER H: Cell Transplantation for Neurological Disorders. Freeman TB, Widner H (Eds), Humana Press, Totowa, NJ, USA (1998).
   Google Scholar
• CAMERON DF, OTHBERG Al, BORLONGAN CV et al.: Post-thaw viability and functionality of cryopreserved rat fetal brain cells cocultured with Sertoli cells [see comments]. Cell Transplant. (1997) 6(2):185–189.
   PubMed Web of Science ®Google Scholar
• OTHBERG Al, WILLING AE, CAMERON DF et al.: Trophic effect of porcine Sertoli cells on rat and human ventral mesencephalic cells and hNT neurons in vitro [published erratum appears in Cell Transplant. (1998) 7(5):497]. Cell Transplant. (1998) 7(2):157–164.
   Google Scholar
• SANBERG PR, BORLONGAN CV, OTHBERG Al et al.: Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. (1997) 3(10):1129–1132.
   PubMed Web of Science ®Google Scholar
• SAPORTA S, CAMERON DF, BORLONGAN CV, SANBERG PR: Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression. Exp. Neurol (1997) 146(2):299–304.
   PubMed Web of Science ®Google Scholar
• SANBERG PR, BORLONGAN CV, SAPORTA S, CAMERON DF: Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain [see comments]. Nat. Biotechnol (1996) 14(13):1692–1695.
   PubMed Web of Science ®Google Scholar
• ••First demonstration that Sertoli cells cansurvive and enable co-transplantation of discordant cells in the brain.
   Google Scholar
• WILLING AE, SUDBERRY JJ, OTHBERG Al et al.: Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum. Brain Res. Bull. (1999) 48(4):441–444.
   PubMed Web of Science ®Google Scholar
• WILLING AE, CAMERON DF, SANBERG PR: Sertoli cell transplants: their use in the treatment of neurodegenerative disease. MM. Med. Today (1998) 4(11):471–477.
   PubMedGoogle Scholar
• BORLONGAN CV, CAMERON DF, SAPORTA S, SANBERG PR: Intracerebral transplantation of testis-derived Sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Exp. Neurol (1997) 148(1):388–392.
   PubMed Web of Science ®Google Scholar
• LIU HW, KUANG YJ, WU JC et al.: Intrastriatal transplantation of Sertoli cells may improve amphetamine-induced rotation and tyrosine hydroxylase immunoreactivity of the striatum in hemiparkinsonian rats. Brain Res. (1999) 838(1-2):227–233.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ Al, WILLING AE, CAMERON DF, SAPORTA S, SANDBERG PR: Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum. Neurotox. Res. (2002) 4(2):103–109.
   PubMedGoogle Scholar
• RODRIGUEZ Al, WILLING AE, SAPORTA S, CAMERON DF, SANBERG PR: Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study. Neurotox. Res. (2003) 5(6):443–450.
   PubMed Web of Science ®Google Scholar
• HEDGER MP, MEINHARDT A: Cones and the immune-testicular axis. .1. Reprod. Immunol. (2003) 58(1):1–26.
   Google Scholar
• •Excellent review on the irnmunoprivileged environment of the testis.
   Google Scholar
• HEDGER MP: Macrophages and the immune responsiveness of the testis. .1. Reprod. Immunol. (2002) 57(1–2):19–34.
   Google Scholar
• POLLANEN P, VON EULER M, SODER 0: Testicular immunoregulatory factors. J. Reprod. Immunol. (1990) 18(1):51–76.
   PubMed Web of Science ®Google Scholar
• FILIPPINI A, RICCIOLI A, PADULA F et al.: Control and impairment of immune privilege in the testis and in semen. Hum. Reprod. Update (2001) 7(5):444–449.
   PubMed Web of Science ®Google Scholar
• STREILEIN JW: Unraveling immune privilege. Science (1995) 270(5239):1158–1159.
   PubMed Web of Science ®Google Scholar
• HEDGER MP: Testicular leukocytes: what are they doing? Rev Reprod. (1997) 2(1):38–47.
   Google Scholar
• TUNG KS, YULE TD, MAHI-BROWN CA, LISTROM MB: Distribution of histopathology and Ia positive cells in actively induced and passively transferred experimental autoimmune orchitis. Immunol. (1987) 138(3):752–759.
   Web of Science ®Google Scholar
• HULEIHEL M, LUNENFELD E, BLINDMAN A, PRINSLOO I, POTASHNIK G: Over expression of interleukin- 1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist in testicular tissues from sexually immature mice as compared to adult mice. Eur. Cytokine Netw. (2003) 14(1):27–33.
   PubMed Web of Science ®Google Scholar
• SODER 0, SULTANA T, JONSSON C et al.: The interleukin-1 system in the testis. Andrologia (2000) 32 (1) :52–55.
   Google Scholar
• ZEYSE D, LUNENFELD E, BECK M, PRINSLOO I, HULEIHEL M: Induction of interleukin-lalpha production in murine Sertoli cells by interleukin-1. Biol. Reprod. (2000) 62(5):1291–1296.
   PubMed Web of Science ®Google Scholar
• STEPHAN JP, SYED V, JEGOU B: Regulation of Sertoli cell IL-1 and IL-6 production M vitro. Mol Cell. Endocrinol (1997) 134(2):109–118.
   PubMed Web of Science ®Google Scholar
• LEGUE F, GUITTON N, BROUAZIN-JOUSSEAUME V et al: IL-6 a key cytokine in in vitro and in vivo response of Sertoli cells to external gamma irradiation. Cytokine (2001) 16(6):232–238.
   PubMed Web of Science ®Google Scholar
• HAAGMANS BL, HOOGERBRUGGE JW, THEMMEN AP, TEERDS KJ: Rat testicular germ cells and Sertoli cells release different types of bioactive transforming growth factor beta in vitro. Reprod. Biol. Endocrinol (2003) 1(1):3.
   PubMedGoogle Scholar
• BELLGRAU D, GOLD D, SELAWRY H et al.: A role for CD95 ligand in preventing graft rejection. Nature (1995) 377(6550):630–632.
   PubMed Web of Science ®Google Scholar
• •Controversial article proposes that FasL expression by Sertoli cells is the primary agent for conferring irnmunoprotection of transplanted islets.
   Google Scholar
• KOJI T, HISHIKAWA Y, ANDO H, NAKANISHI Y, KOBAYASHI N: Expression of Fas and Fas ligand in normal and ischemia-reperfusion testes: involvement of the Fas system in the induction of germ cell apoptosis in the damaged mouse testis. Biol. Reprod. (2001) 64(3):946–954.
   PubMed Web of Science ®Google Scholar
• MEINHARDT A, BACHER M, O'BRYAN MK et al.: A switch in the cellular localization of macrophage migration inhibitory factor in the rat testis after ethane dimethane sulfonate treatment. J. Cell ScL (1999) 112\(Pt 9):1337–1344.
   Google Scholar
• BAILEY RW, DUNKER AK, BROWN CJ, GARNER EC, GRISWOLD MD: Clusterin, a binding protein with a molten globule-like region. Biochemistry (2001) 40(39):11828–11840.
   PubMed Web of Science ®Google Scholar
• DE CESARIS P, FILIPPINI A, CERVELLI C et al.: Immunosuppressive molecules produced by Sertoli cells cultured M vitro: biological effects on lymphocytes. Biochem. Biophys. Res. Commun. (1992) 186(3):1639–1646.
   PubMed Web of Science ®Google Scholar
• SELAWRY HP, KOTB M, HERROD HG, LU ZN: Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation (1991) 52(5):846–850.
   Google Scholar
• LEE HO, FERGUSON TA: Biology of FasL. Cytokine Growth Factor Rev (2003) 14(3-4):325–335.
   PubMed Web of Science ®Google Scholar
• LAN P, ZHAN W, WANG Jet al.: Immune privilege induced by cotransplantation of islet and allogeneic testicular cells. ChM. Med. (Engl.) (2001) 114(10):1026–1029.
   Google Scholar
• ZHAN W, CATS, WANG J et al: The effect of FasL expression on pancreatic islet allografts. Chin. Med. I (Engl.) (2002) 115(7):1006–1009.
   PubMed Web of Science ®Google Scholar
• HSU PN, UN HH, TU CF et al.: Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts. Eton-led. Sci. (2001) 8(3):262–269.
   Google Scholar
• KANG SM, SCHNEIDER DB, UN Z et al.: Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat. Med. (1997) 3(7):738–743.
   PubMed Web of Science ®Google Scholar
• •This and [72] contradict the findings from Bellgrau et al. [61] - that FasL is key for irnmunoprotection. The potential issues with these articles may be that FasL was not regulated in its expression.
   Google Scholar
• ALLISON J, GEORGIOU HM, STRASSER A, VAUX DL: Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. ScL USA (1997) 94(8):3943–3947.
   PubMed Web of Science ®Google Scholar
• •See [71].
   Google Scholar
• ABDI R, MEANS TK, LUSTER AD: Chemokines in islet allograft rejection. Diabetes Metab. Res. Rev (2003) 19(3):186–190.
   PubMed Web of Science ®Google Scholar
• MOORE C, HUTSON JC: Physiological relevance of tumor necrosis factor in mediating macrophage-Leydig cell interactions. Endocrinology (1994) 134(1):63–69.
   PubMed Web of Science ®Google Scholar
• MAUDUIT C, BESSET V, CAUSSANEL V, BENAHMED M: Tumor necrosis factor alpha receptor p55 is under hormonal (follicle-stimulating hormone) control in testicular Sertoli cells. Biochem. Biophys. Res. Commun. (1996) 224(3):631–637.
   PubMed Web of Science ®Google Scholar
• RICCIOLI A, FILIPPINI A, DE CESARIS P et al.: Inflammatory mediators increase surface expression of integrin ligands, adhesion to lymphocytes, and secretion of interleukin 6 in mouse Sertoli cells. Proc. Natt Acad. Sci. USA (1995) 92(13):5808–5812.
   Google Scholar
• BELLGRAU D, SELAWRY HP: Cyclosporine-induced tolerance to intratesticular islet xenografts. Transplantation (1990 Oct) 50(4):654–657.
   PubMed Web of Science ®Google Scholar
• DUFOUR JM, HEMENDINGER R, HALBERSTADT CR et al.: Genetically engineered Sertoli cells are able to survive allogeneic transplantation. Gene Ther. (2004) 11(8):694–700.
   PubMed Web of Science ®Google Scholar
• •This reference presents the possibility of using animal transgenic Sertoli cells as a means for delivering therapeutic proteins.
   Google Scholar
• HEMENDINGER RA, GORES P, BLACKSTEN L, HARLEY V, HALBERSTADT C: Identification of a specific Sertoli cell marker, Sox9, for use in transplantation. Cell Transplant. (2002) 11(6):499–505.
   PubMed Web of Science ®Google Scholar
• DUFOUR JM, GORES P, HEMENDINGER R, EMERICH DF, HALBERSTADT CR: Transgenic Sertoli cells as a vehicle for gene therapy. Cell Transplant. (2004) 13(1):1–6.
   PubMed Web of Science ®Google Scholar
• EMERICH DF, HEMENDINGER R, HALBERSTADT CR: The testicular-derived Sertoli cell: cellular immunoscience to enable transplantation. Cell Transplant. (2003) 12(4):335–349.
   PubMed Web of Science ®Google Scholar
• VALDES-GOMZALAEZ RA, ELLIOTT RB, DORANTES LM et al: Porcine islet xenografts can survive and function in type 1 diabetic patients in the presence of both pre-existing and elicited anti-pig antibodies. XIX International Congress of the Transplantation Socien". Miami, USA (25–30 August 2002).
   Google Scholar
• BIRMINGHAM K: Skepticism surrounds diabetes xenograft experiment. Nat. Med. (2002) 8(10):1047.
   PubMedGoogle Scholar
• CHECK E: Diabetes trial stirs debate on safety of xenotransplants. Nature (2002) 419(6902):5.
   PubMed Web of Science ®Google Scholar
• CLEMENCEAU B, JEGOU D, MARTIGNAT L, SAT P: Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Diabetologia (2002) 45(6):914–923.
   PubMed Web of Science ®Google Scholar
• SWITZER WM, MICHLER RE, SHANMUGAM V et al: Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation (2001) 71(7):959–965.
   PubMed Web of Science ®Google Scholar
• ROSSINI AA, GREINER DL, MORDES JP: Induction of immunologic tolerance for transplantation. Physiol Rev (1999) 79(1):99–141.
   PubMed Web of Science ®Google Scholar
• POLLANEN P, VON EULER M, JAHNUKAINEN K et al.: Role of transforming growth factor beta in testicular immunosuppression. Reprod. brimunol. (1993) 24(2):123–137.
   PubMed Web of Science ®Google Scholar
• HULEIHEL M, LUNENFELD E: Involvement of intratesticular IL-1 system in the regulation of Sertoli cell functions. MM. Cell. Endocrinol (2002) 187(1-2):125–132.
   PubMed Web of Science ®Google Scholar
• PETERSEN C, BOITANI C, FROYSA B, SODER 0: Interleuldn-1 is a potent growth factor for immature rat Sertoli cells. MM. Cell. Endocrinol (2002) 186(1):37–47.
   PubMed Web of Science ®Google Scholar
• DE CESARIS P, STARACE D, RICCIOLI A et al.: Tumor necrosis factor-alpha induces interleuldn-6 production and integrin ligand expression by distinct transduction pathways. I. Biol. Chem. (1998) 273(13):7566–7571.
   Web of Science ®Google Scholar
• JENNE DE, TSCHOPP J: Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc. Natt Acad. Sci. USA (1989) 86(18):7123–7127.
   PubMed Web of Science ®Google Scholar
• BAILEY RW, ARONOW B, HARMONY JA, GRISWOLD MD: Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/ApoJ knock-out mice. Biol. Reprod. (2002) 66(4):1042–1053.
   PubMed Web of Science ®Google Scholar
• VERAJAKORVA E, LAATO M, POLLANEN P: CD 99 and CD 106 (VCAM-1) in human testis. Asian I Andra (2002) 4(4):243–248.
   PubMed Web of Science ®Google Scholar
• MARTI HH, RISAU W: Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Nail Acad. Sci. USA (1998) 95(26):15809–15814.
   PubMed Web of Science ®Google Scholar
• ERGUN S, KILIC N, FIEDLER W, MUKHOPADHYAY AK: Vascular endothelial growth factor and its receptors in normal human testicular tissue. MoL Endocrinol (1997) 131(1):9–20.
   Web of Science ®Google Scholar
• ZAKIN MM, BARON B, GUILLOU F: Regulation of the tissue-specific expression of transferrin gene. Dev. Neuresci. (2002) 24(2-3):222–226.
   PubMed Web of Science ®Google Scholar
• SYLVESTER SR, GRISWOLD MD: The testicular iron shuttle: a 'nurse' function of the Sertoli cells. J. Andrei (1994) 15(5):381–385.
   PubMed Web of Science ®Google Scholar
• SKINNER MK, GRISWOLD MD: Sertolicells synthesize and secrete transferrin-like protein. J. Biel. Chem. (1980) 255(20):9523–9525.
   PubMed Web of Science ®Google Scholar
• SKINNER MK, COSAND WL, GRISWOLD MD: Purification and characterization of testicular transferrin secreted by rat Sertoli cells. Biechem. (1984) 218(2):313–320.
   PubMed Web of Science ®Google Scholar
• GNESSI L, EMIDI A, JANNINI EA et al.: Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action. J. Cell Biel. (1995) 131(4):1105–1121.
   PubMed Web of Science ®Google Scholar
• MAGNANTI M, GANDINI 0, GIULIANI L et al.: Erythropoietin expression in primary rat Sertoli and peritubular myoid cells. Bleed (2001) 98(9):2872–2874.
   Google Scholar
• CANIPARI R, GALDIERI M: Retinoid modulation of plasminogen activator production in rat Sertoli cells. Biel. Repred. (2000) 63(2):544–550.
   PubMed Web of Science ®Google Scholar
• CLARK AM, GARLAND KK, RUSSELL LD: Desert hedgehog (Dhh) gene is required in the mouse testis for formation of adult-type Leydig cells and normal development of peritubular cells and seminiferous tubules. Biel. Repred. (2000) 63(6):1825–1838.
   PubMed Web of Science ®Google Scholar
• BITGOOD MJ, SHEN L, MCMAHON AP: Sertoli cell signaling by Desert hedgehog regulates the male germline. Curt: Biol. (1996) 6(3):298–304.
   PubMed Web of Science ®Google Scholar
• MULLANEY BP, SKINNER MK: Basic fibroblast growth factor (bEGF) gene expression and protein production during pubertal development of the seminiferous tubule: follicle-stimulating hormone-induced Sertoli cell bEGF expression. End ecri nelegy (1992) 131(6):2928–2934.
   Google Scholar
• RICHARDSON LL, KLEINMAN HK, DYM M: Basement membrane gene expression by Sertoli and peritubular myoid cells in vitro in the rat. Biel. Repred. (1995) 52(2):320–330.
   PubMed Web of Science ®Google Scholar
• SKINNER MK, FRITZ IB: Structural characterization of proteoglycans produced by testicular peritubular cells and Sertoli cells. Biel. Chem. (1985) 260(21):11874–11883.
   PubMedGoogle Scholar